Zepbound (tirzepatide) is an FDA-approved prescription medication for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea
However, the effectiveness of Wegovy relies on creating a sustained calorie deficit alongside the medication's appetite-suppressing effects
For nausea management during semaglutide treatment, ondansetron or other 5-HT3 antagonists are preferred over agents that speed stomach emptying
However, rapid weight loss comes with the risk of developing loose, sagging skin that can negatively affect your self-image
Currently under investigation for obesity, type 2 diabetes, and metabolic liver diseases
Frequently Asked Questions How long does acid reflux last when starting semaglutide